Twenty-year experience with the St. Jude Medical Biocor bioprosthesis in the aortic position

  • Walter Eichinger


Bioprostheses are prone to continuous degeneration, which over time may lead to structural valve deterioration (SVD). In turn, SVD may require reoperation [1, 2, 3]. Improvements in valve design and conservation methods have extended the lifetime of bioprotheses [4, 5]. Thus, data on valve dysfunction and the risk of reoperation over the long term are of particular interest.


International Normalize Ratio Heart Valve Jude Medical Prosthetic Valve Endocarditis Paravalvular Leakage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Oxenham H, Bloomfield P, Wheatley DJ et al (2003) Twenty-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart 89(7):715–721CrossRefPubMedGoogle Scholar
  2. 2.
    Bonow RO, Carabello BA, Kanu C et al (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114(5):e84–e231CrossRefPubMedGoogle Scholar
  3. 3.
    Bortolotti U, Milano A, Mossuto E, Mazzaro E, Thiene G, Cassorotto D (1995) Porcine valve durability: a comparison between Hancock standard and Hancock II bioprostheses. Ann Thorac Surg 60(2 Suppl):S216–S220CrossRefPubMedGoogle Scholar
  4. 4.
    Vesely I (1991) Analysis of the Medtronic Intact bioprosthetic valve. Effects of “zero-pressure” fixation. J Thorac Cardiovasc Surg 101(1):90–99PubMedGoogle Scholar
  5. 5.
    Vrandecic MO, Gontijo Filho B, Paula e Silva JA et al (1991) Clinical results with the Biocor porcine bioprosthesis. J Cardiovasc Surg (Torino) 32(6):807–813Google Scholar
  6. 6.
    Edmunds Jr LH, Clark Re, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD (1996) Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 62(3):932–935CrossRefPubMedGoogle Scholar
  7. 7.
    Johnson DM, Sapirstein W (1994) FDA’s requirements for in-vivo performance data for prosthetic heart valves. J Heart Valve Dis 3(4):350–355PubMedGoogle Scholar
  8. 8.
    Grunkemeier GL, Jin R, Eijkemans JM, Takkenberg JJ (2007) Actual and actuarial probabilities of competing risks: apples and lemons. Ann Thorac Surg 83(5):1586–1592CrossRefPubMedGoogle Scholar
  9. 9.
    Bech-Hanssen O, Wallentin I, Larsson S, Caidahl K. (1998) Reference Doppler echocardiographic values for St. Jude Medical, Omnicarbon and Biocor prosthetic valves in the aortic position. J Am Soc Echocardiogr 11(5):466–477CrossRefPubMedGoogle Scholar
  10. 10.
    Bottio T, Rizzoli G, Thiene G, Nesseris G, Casarotto D, Gerosa G (2004) Hemodynamic and clinical outcomes with the Biocor valve in the aortic position: an eight-year experience. J Thorac Cardiovasc Surg 127(6):1616–1623CrossRefPubMedGoogle Scholar
  11. 11.
    Myken PS (2005) Seventeen-year experience with the St. Jude Medical Biocor porcine bioprosthesis. J Heart Valve Dis 14(4):486–492PubMedGoogle Scholar
  12. 12.
    Dellgren G, Eriksson, MJ, Brodin, LA, Radegran K (2002) Eleven years’ experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic followup with long-term relative survival rate. Eur J Cardiothorac Surg 22(6):912–921CrossRefPubMedGoogle Scholar
  13. 13.
    Jamieson WR, Burr LH, Miyagishima RT et al (2005) Carpentier-Edwards supraannular aortic porcine bioprosthesis: clinical performance over 20 years. J Thorac Cardiovasc Surg 130(4):994–1000CrossRefPubMedGoogle Scholar
  14. 14.
    Kirali K, Guler M, Tuncer A et al (2001) Fifteen-year clinical experience with the Biocor porcine bioprosthesis in the mitral position. Ann Thorac Surg 71(3):811–815CrossRefPubMedGoogle Scholar
  15. 15.
    Fann JI, Miller DC, Moore KA et al (1996) Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg 62(5):1301–1311, discussion 1311–1312CrossRefPubMedGoogle Scholar
  16. 16.
    Jamieson WR, Burr LH, Munro AI, Miyagishima RT (1998) Carpentier-Edwards standard porcine bioprosthesis: a 21-year experience. Ann Thorac Surg 66(6 Suppl): S40–S43CrossRefPubMedGoogle Scholar
  17. 17.
    Emery RW, Krogh CC, Arom KV et al (2005) The St. Jude Medical Cardiac Valve Prosthesis: A 25-year experience with single valve replacement. Ann Thorac Surg 79(3):776–782CrossRefPubMedGoogle Scholar
  18. 18.
    Nelson MR, Liew D, Bertram M, Vos T (2005) Epidemiological modeling of routine use of low-dose aspirin for the primary prevention of coronary heart disease and stroke in those aged > or =70. BMJ 330(7503):1306CrossRefPubMedGoogle Scholar
  19. 19.
    Minami KA, Zitterman S, Schulte-Eistrup S, Koertle H, Korfer R (2005) Mitroflow synergy prostheses for aortic valve replacement: 19 years’ experience with 1516 patients. Ann Thorac Surg 80(5):1699–1705CrossRefPubMedGoogle Scholar
  20. 20.
    Kolominsky-Rabas PL, Sarti C, Heuschmann PU et al (1998) A prospective community-based study of stroke in Germany — the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3 and 12 months. Stroke 29(12):2501–2506PubMedGoogle Scholar
  21. 21.
    Aupart MR, Mirza A, Meurisse Y.A., Sirinelli AL, Neville PH, Marchand MA (2006) Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1, 133 patients. J Heart Valve Dis 15(6):768–775, discussion 775–776PubMedGoogle Scholar
  22. 22.
    Borger MA, Ivanov J, Armstrong S, Christie-Hrybinsky D, Feindel CM, David TE (2006) Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis 15(1):49–55, discussion 55–56PubMedGoogle Scholar
  23. 23.
    Yankah CA, Schubel J, Buz S, Siniawski H, Hetzer R (2005) Seventeen-year clinical results of 1037 Mitroflow pericardial heart valve prostheses in the aortic position. J Heart Valve Dis 14(2):172–179, discussion 179–180PubMedGoogle Scholar
  24. 24.
    Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S (1993) A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med 328(18):1289–1296CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Walter Eichinger
    • 1
  1. 1.Klinik für Herzchirurgie im Klinikum München-BogenhausenStädtisches Klinikum MünchenMünchenGermany

Personalised recommendations